Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

The American journal of gastroenterology·2025
Same author

Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis.

Liver international : official journal of the International Association for the Study of the Liver·2023
Same author

Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.

Alimentary pharmacology & therapeutics·2022
Same author

Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas.

JHEP reports : innovation in hepatology·2021
Same author

Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.

United European gastroenterology journal·2021
Same author

A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.

The American journal of gastroenterology·2021

Related Experiment Video

Updated: Jun 18, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

[Primary biliary cirrhosis].

Edith M M Kuiper1, Jannie W den Ouden-Muller, Henk R van Buuren

  • 1Erasmus MC, afd. Maag-, Darm- en Leverziekten, Rotterdam, The Netherlands.

Nederlands Tijdschrift Voor Geneeskunde
|November 11, 2009
PubMed
Summary
This summary is machine-generated.

Primary biliary cirrhosis (PBC) is a progressive autoimmune liver disease affecting middle-aged women. Early diagnosis and treatment with ursodeoxycholic acid can lead to a normal prognosis for PBC patients.

Related Experiment Videos

Last Updated: Jun 18, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Area of Science:

  • Hepatology
  • Autoimmune Diseases
  • Gastroenterology

Context:

  • Primary biliary cirrhosis (PBC) affects thousands in the Netherlands, primarily middle-aged women.
  • PBC is a slowly progressive liver disease with autoimmune characteristics, but its exact cause is unknown.
  • Key symptoms include fatigue and pruritus, though some patients remain asymptomatic.

Purpose:

  • To outline the diagnostic criteria for primary biliary cirrhosis.
  • To discuss the current understanding of PBC aetiology and presentation.
  • To highlight the prognostic implications of early diagnosis and treatment.

Summary:

  • Diagnosis involves cholestatic liver tests, antimitochondrial antibodies, and liver biopsy findings.
  • Most patients are currently diagnosed in the early stages of the disease.
  • Ursodeoxycholic acid treatment offers a normal prognosis for patients diagnosed early.

Impact:

  • Improves understanding of primary biliary cirrhosis epidemiology and clinical features.
  • Emphasizes the importance of early detection and intervention in managing PBC.
  • Provides insights into the effectiveness of ursodeoxycholic acid in improving patient outcomes.